Article
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
25 Mar 2022
Abstract excerpt
BACKGROUND: The response rates of the clinical chemotherapies are still low in clear cell renal cell carcinoma (ccRCC). Computational drug repositioning is a promising strategy to discover new uses for existing drugs to treat patients who cannot get benefits from clinical drugs. METHODS: We proposed a systematic approach which included the target prediction based on the co-expression network analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
